Assessment for frailty is useful for predicting morbidity in elderly patients undergoing colorectal cancer resection whose comorbidities are already optimized

1 Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type k-ras colorectal carcinoma Journal of Clinical Oncology, May 23, 2013

2 Exercise, PTGS2 expression, and colorectal cancer survival Cancer Epidemiology, Biomarkers & Prevention, May 23, 2013

3 Serum mir-21 as a diagnostic and prognostic biomarker in colorectal cancer Journal of the National Cancer Institute, May 28, 2013

4 Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy Journal of Diabetes and its Complications, June 10, 2013

5 Risk of advanced proximal neoplasms according to distal colorectal findings: comparison of sigmoidoscopy-based strategies Journal of the National Cancer Institute, May 29, 2013

6 Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? Journal of Cancer Survivorship, May 23, 2013    Review Article

7 Risk for coronary heart disease increases risk for colorectal neoplasm Clinical Gastroenterology and Hepatology , May 22, 2013

8 Panitumumab and irinotecan versus irinotecan alone for patients with wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial The Lancet Oncology, May 31, 2013
Exclusive Author Commentary

9 Assessment of volumetric growth rates of small colorectal polyps with CT colonography: a longitudinal study of natural history The Lancet Oncology, June 11, 2013

10 The effect of statins on risk and survival of gynecological malignancies Gynecologic Oncology, May 29, 2013
Exclusive Author Commentary